Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution
2022 · bioRxiv (Cold Spring Harbor Laboratory) · 394 citations
https://doi.org/10.1101/2022.09.15.507787
Y
Yanli Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
9.7K
Citations
19
h-index
30
i10-index
Yanli Xu is an academic researcher from Central China Normal University. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & SARS-CoV-2 detection and testing. The author has an h-index of 19, co-authored 57 publications.
Papers by this author
worksFast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
2023 · The Lancet Infectious Diseases · 378 citations
https://doi.org/10.1016/s1473-3099(23)00744-2
Neutrophil-to-Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage
2020 · medRxiv · 328 citations
https://doi.org/10.1101/2020.02.10.20021584
Repeated Omicron exposures override ancestral SARS-CoV-2 immune imprinting
2023 · Nature · 250 citations
https://doi.org/10.1038/s41586-023-06753-7
SARS-CoV-2–Positive Sputum and Feces After Conversion of Pharyngeal Samples in Patients With COVID-19
2020 · Annals of Internal Medicine · 244 citations
https://doi.org/10.7326/m20-0991
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1
2024 · Nature · 123 citations
https://doi.org/10.1038/s41586-024-08315-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat